Alan W. Dunton
CIK: 0001304773
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Aug 3, 2026PTN
PALATIN TECHNOLOGIES INC
Trust(Z)DirectStockOption (Right toBuy)
2.2K shares- - Jan 26, 2026CRMD
CorMedix Inc.
Award(A)Direct30.5K shares- - Dec 30, 2025CRMD
CorMedix Inc.
Exercise(M)Direct20K shares at avg. $4.03$81K - Dec 30, 2025CRMD
CorMedix Inc.
Sale(S)Direct20K shares at avg. $13.00$260K - Dec 11, 2025OGEN
ORAGENICS INC
Award(A)DirectNon-Employee Director Option (Right to Buy)
125K shares- - Dec 9, 2025PTN
PALATIN TECHNOLOGIES INC
Award(A)Direct1K shares- - Dec 9, 2025PTN
PALATIN TECHNOLOGIES INC
Award(A)Direct1K shares- - Sep 12, 2025CRMD
CorMedix Inc.
Sale(S)Direct10K shares at avg. $13.13$131K - Sep 12, 2025CRMD
CorMedix Inc.
Exercise(M)Direct10K shares at avg. $3.55$36K - Jun 13, 2025PTN
PALATIN TECHNOLOGIES INC
Purchase(P)Direct200 shares at avg. $20000.00$4.0M - Jan 17, 2025CRMD
CorMedix Inc.
Award(A)Direct25K shares- - Dec 6, 2024OGEN
ORAGENICS INC
Sale(S)Direct66 shares at avg. $0.36$23.76 - Sep 19, 2024OGEN
ORAGENICS INC
Award(A)DirectNon-Employee Director Option (Right to Buy)
65K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 3, 2026 |  PTN PALATIN TECHNOLOGIES INC | Trust(Z) StockOption (Right toBuy) | 2,200 | - | - | Direct |
| Jan 26, 2026 |  CRMD CorMedix Inc. | Award(A) | 30,453 | - | $0 | Direct |
| Dec 30, 2025 | CRMD CorMedix Inc. | Exercise(M) | 20,000 | $4.03 | $80,600 | Direct |
| Dec 30, 2025 | CRMD CorMedix Inc. | Sale(S) | 20,000 | $13.00 | $260,000 | Direct |
| Dec 11, 2025 |  OGEN ORAGENICS INC | Award(A) Non-Employee Director Option (Right to Buy) | 125,000 | - | - | Direct |
| Dec 9, 2025 | PTN PALATIN TECHNOLOGIES INC | Award(A) | 1,000 | - | - | Direct |
| Dec 9, 2025 | PTN PALATIN TECHNOLOGIES INC | Award(A) | 1,000 | - | - | Direct |
| Sep 12, 2025 | CRMD CorMedix Inc. | Sale(S) | 10,000 | $13.13 | $131,300 | Direct |
| Sep 12, 2025 | CRMD CorMedix Inc. | Exercise(M) | 10,000 | $3.55 | $35,500 | Direct |
| Jun 13, 2025 | PTN PALATIN TECHNOLOGIES INC | Purchase(P) | 200 | $20000.00 | $4,000,000 | Direct |
| Jan 17, 2025 | CRMD CorMedix Inc. | Award(A) | 25,000 | - | $0 | Direct |
| Dec 6, 2024 | OGEN ORAGENICS INC | Sale(S) | 66 | $0.36 | $24 | Direct |
| Sep 19, 2024 | OGEN ORAGENICS INC | Award(A) Non-Employee Director Option (Right to Buy) | 65,000 | - | - | Direct |
1-13 of 13 transactions
About DUNTON ALAN W
DUNTON ALAN W (SEC CIK 0001304773) files insider reports with the SEC as Director of PALATIN TECHNOLOGIES INC (PTN), Director of CorMedix Inc. (CRMD) and Director of ORAGENICS INC (OGEN).
Signal8 holds 10 ownership filings by DUNTON ALAN W, all Form 4s, filed between Sep 20, 2024 and Aug 5, 2026. Those filings report 13 transactions, from Sep 19, 2024 to Aug 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on DUNTON ALAN W's filings is in PRINCETON,, NJ.
Recent filings by DUNTON ALAN W
- Aug 3, 2026: Voting trust transaction of PTN derivative securities (Form 4, code Z).
- Jan 26, 2026: Grant or award of CRMD shares (Form 4, code A).
- Dec 30, 2025: Option exercise of CRMD shares (Form 4, code M).
- Dec 30, 2025: Open-market sale of CRMD shares (Form 4, code S).
- Dec 11, 2025: Grant or award of OGEN derivative securities (Form 4, code A).
Other insiders filing for PALATIN TECHNOLOGIES INC (PTN)
- Morris Arlene, Director
- PRENDERGAST JOHN K A, Director
- SPANA CARL, President and CEO
- WILLS STEPHEN T, Executive VP and CFO/COO
- DEVEER ROBERT K JR, Director